A replay of the earnings webcast will be accessible on Resmed’s investor relations website and available approximately two hours after the webcast. In addition, a phone replay will be available ...

Since July 2025, ResMed has been in a holding pattern, floating around $254.41. The stock also fell short of the S&P 500’s 11 ...

ResMed will release its second-quarter earnings soon, and analysts anticipate a low double-digit bottom-line growth.

With Q3 behind us, let’s have a look at ResMed (NYSE:RMD) and its peers. Patient monitoring companies within the healthcare ...

The sleep tech devices market is expected to grow significantly in the coming years, driven by the rising number of people affected by sleep disorders such as insomnia and obstructive sleep apnea, the ...

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ) has provided an update. An executive of ResMed Inc., officer ...

The global respiratory device market witnessed substantial growth, reaching USD 15.8 billion in 2020 and is projected to reach USD 38.0 billion by 2027, with a notable CAGR of 13.5% during the ...

Detailed price information for Boston Beer Company (SAM-N) from The Globe and Mail including charting and trades.

ResMed is betting big on artificial intelligence (AI) to boost CPAP adherence. At the recent J.P. Morgan Healthcare Conference, CEO Mick Farrell said the company’s first AI-enabled medical device, Sma ...

As millions prepare to set New Year's resolutions centered on "eating clean" and "getting fit," new research suggests these habits could also benefit your pillow time. An American Academy of Sleep ...

(HealthDay News) — A multimodal sleep foundation model based on polysomnography data can predict the risk for multiple conditions, including death, dementia, and myocardial infarction (MI), according ...